Skip to main navigation Skip to search Skip to main content

Reflecting on the current human enhancement drugs categorisation and new directions to consider

  • Katinka van de Ven
  • , Geoff Bates
  • , Rebecca Askew
  • , Kyle Mulrooney
  • , Jim McVeigh
  • 360Edge
  • University of New England
  • Manchester Metropolitan University

Research output: Chapter or section in a book/report/conference proceedingBook chapter

Abstract

The recognition of human enhancement drugs (HEDs) as a distinct categorisation of substances is a relatively recent phenomenon. HEDs are currently divided into six sub-categories based on their reason for use. Specifically, drugs used to enhance: (1) the structure and function of muscle; (2) weight loss; (3) the appearance of the skin and hair; (4) sexual function and behaviour; (5) cognitive function; and (6) mood and social behaviour. While this provides a useful framework for describing the different types of HEDs, this categorisation would benefit from further development and refinement. Several complexities regarding HEDs were highlighted in the initial categorisation but were not fully explored; for instance, the six categories are not mutually exclusive, some substances are not solely HEDs but may also be prescribed for therapeutic purposes, and psychoactive drugs may also have enhancing effects. The issue is further complicated by the fact that there may not be scientific evidence to support a specific reason for the use of a substance. However, that is not seen as a barrier by consumers, particularly those looking to enhance cognition or sexual performance. This chapter revisits the HED taxonomy, reflect on the issues associated with HED categorisation, and explore the next steps in how we can better understand the use of these substances.
Original languageEnglish
Title of host publicationHuman Enhancement Drugs
Subtitle of host publicationVolume 2
EditorsKatinka van de Ven, Kyle J. D. Mulrooney, Jim McVeigh
Place of PublicationLondon
PublisherRoutledge
Chapter1
Pages1-12
Number of pages12
Volume2
Edition1st
ISBN (Electronic)9781003391067
ISBN (Print)9781032488370
Publication statusPublished - 22 Jan 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anabolic steroids
  • Drugs
  • Body image
  • Public Health

Fingerprint

Dive into the research topics of 'Reflecting on the current human enhancement drugs categorisation and new directions to consider'. Together they form a unique fingerprint.

Cite this